Global biopharmaceutical processing equipment and

Newark, NJ, May 24, 2022 (GLOBE NEWSWIRE) — A recently released report titled, The global biopharmaceutical processing equipment and consumables market is expected to grow from USD 32.55 billion in 2021 to USD 78.02 billion by 2030, at a CAGR of 10.2% during the forecast period 2022-2030.

The growth of the biopharmaceutical processing equipment and consumables market is majorly attributed to the various industries contributing to the adoption of biopharmaceuticals, increasing use of single-use bioprocessing in commercial bioproduction, increase in drug developments customized and the transition to bioprocessing industries 4.0 which may present market development prospects. Single-use systems (SUS) are primarily used for more than 82% of clinical-scale bioprocessing functions. Contract manufacturing organizations (CMOs) and biologics manufacturers are expected to adopt these systems significantly as SUS products in the pipeline are increasingly approved and enter commercial production.

Competitive Strategy

To strengthen their position in the global biopharmaceutical processing equipment and consumables market, the major players are now focusing on adopting strategies such as product innovations, mergers and acquisitions, recent developments, joint ventures, collaborations and partnerships.

  • In May 2021, Moderna Inc. began upgrading its Massachusetts manufacturing building to expand its COVID-19 facility. Additionally, a biopharmaceutical company, Amgen, Inc., disclosed the construction of the final manufacturing unit at the facility in Holly Springs, North Carolina.

Get Sample Copy with TOC, Charts and List of Figures @ https://www.marketsandresearch.biz/sample-request/301662

Market growth and trends

Biopharmaceutical treatment includes actions focused on the manufacture of biomolecules such as viral vectors, monoclonal antibodies (mAb), recombinant proteins and different products of the biological source. Bioprocessing equipment includes:

  • Bioreactor vessels.
  • Chromatography equipment and consumables.
  • All associated tools maintain streamlined reactions in sterile environments.
  • Filtration systems

Bioprocessing can be carried out either by continuous processing or by batch processing. Growing cost pressures in the pharmaceutical industry, outcome-based treatment orientation, growing challenges and competition, and growing need for therapeutics due to the growing geriatric population and rising popularity associated chronic diseases have increased the need for more complex individualized treatments. . According to data from the International Federation of Pharmaceutical Manufacturers and Associations (2021), there are approximately 8,000 biopharmaceuticals in various stages of expansion worldwide. Among all industries, the biopharmaceutical industry has sought to increase investment in research and development.

Main conclusions

  • In 2021, the filtration segment dominated the market with the largest market share of 18% and revenue of 5.85 billion.

The type segment is divided into chromatography, columns, cell culture, filtration, service and bioreactor. In 2021, the filtration segment dominated the market with the largest market share of 18% and revenue of 5.85 billion. The filtration procedure is the main requirement in all phases of bioproduction. Filtration is generally used in biopharmaceutical processes to isolate elements. It is leveraged in different downstream functions, such as filtration of intermediates, upstream processing for sterilizing grade filtration of cell culture media, and critical end-fill applications. The highest share of remuneration is attributed to the regular use of filtration at each stage of the bioprocess and to technical improvements in filtration technologies.

  • In 2021, the commercial segment dominated the market with the largest market share of 62% and market revenue of 20.18 billion.

The applications segment is divided into research and commercial. In 2021, the commercial segment dominated the market with the largest market share of 62% and market revenue of 20.18 billion. The growing and increasing approvals of biopharmaceuticals reinforce the need for bioprocessing tools and consumables for commercial bioproduction. Biosimilar rate consumption is slowly growing. The moderate penetration of biosimilars established before 2019 for different therapeutic areas has increased from 12.5% ​​in 2019 to 60.5% in 2021. Therefore, the increasing adoption of biosimilars reinforces the need for bioprocessing technologies.

Regional Segment Analysis of Biopharmaceutical Processing Equipment and Consumables Market

  • North America (United States, Canada, Mexico)
  • Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, rest of APAC)
  • South America (Brazil and rest of South America)
  • Middle East and Africa (UAE, South Africa, Rest of MEA)

Among all regions, Asia-Pacific has emerged as the largest market for the global biopharmaceutical processing equipment and consumables market, with a market share of around 35% and 11.39 billion market revenue in 2021 The development of the market is associated with increasing outsourcing of biopharmaceutical manufacturing to countries like India, Singapore, South Korea, and China, rising biotechnology spending by governments, and growing initiatives supporting the adoption of biopharmaceuticals. Additionally, the increasing understanding of personalized treatments and the growth of biotechnology incubators are also driving the growth of the market.

To learn more about additional highlights and key points, visit our report @ https://www.marketsandresearch.biz/report/301662/global-biopharmaceutical-processing-equipment-and-consumable-market-2022-by- company-regions-type-and-application-forecast-until-2028

Leading players operating in the global biopharmaceutical processing equipment and consumables market are:

  • 3M Company
  • AgilentTechnologies
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Eppendorf AG
  • GE
  • Merck Group
  • Repligen Corporation
  • Sartorius
  • Thermo Fisher Scientific

This study forecasts revenue at global, regional and country levels from 2019 to 2030. Markets and research has segmented the global biopharmaceutical processing equipment and consumables market based on the segments mentioned below:

Global Biopharmaceutical Processing Equipment and Consumables Market By Type:

  • Chromatography
  • Columns
  • Cell culture
  • Filtration
  • A service
  • Bioreactor

Global Biopharmaceutical Processing Equipment and Consumables Market By Application:

To Buy Research Report @ https://www.marketsandresearch.biz/buy-now/301662/single

About the report:

The global biopharmaceutical processing equipment and consumables market is analyzed based on value (USD billion). All segments have been analyzed on a global, regional and country basis. The study includes analysis of more than 30 countries for each part. The report offers an in-depth analysis of the drivers, opportunities, restraints and challenges to gain a critical overview of the market. The study includes Porter’s five forces model, attractiveness analysis, raw material analysis, supply, demand analysis, competitor position analysis, distribution and marketing channel analysis.

Contact us

Avinash D
Business Development Manager
Call: 1-201-465-4211
E-mail: [email protected]

Comments are closed.